146 related articles for article (PubMed ID: 30143500)
41. CCL5-403, CCR5-59029, and Delta32 polymorphisms and cancer risk: a meta-analysis based on 20,625 subjects.
Ying H; Wang J; Gao X
Tumour Biol; 2014 Jun; 35(6):5895-904. PubMed ID: 24687549
[TBL] [Abstract][Full Text] [Related]
42. Association between XRCC3 rs861539 Polymorphism and the Risk of Ovarian Cancer: Meta-Analysis and Trial Sequential Analysis.
Hu S; Jing Y; Liu F; Han F
Biomed Res Int; 2022; 2022():3915402. PubMed ID: 35978646
[TBL] [Abstract][Full Text] [Related]
43. The association between the APE1 Asp148Glu polymorphism and prostate cancer susceptibility: a meta-analysis based on case-control studies.
Zhou X; Wei L; Jiao G; Gao W; Ying M; Wang N; Wang Y; Liu C
Mol Genet Genomics; 2015 Feb; 290(1):281-8. PubMed ID: 25234162
[TBL] [Abstract][Full Text] [Related]
44. Association of IREB2 Gene rs2568494 Polymorphism with Risk of Chronic Obstructive Pulmonary Disease: A Meta-Analysis.
Du Y; Xue Y; Xiao W
Med Sci Monit; 2016 Jan; 22():177-82. PubMed ID: 26775557
[TBL] [Abstract][Full Text] [Related]
45. TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls.
Liao RY; Mao C; Qiu LX; Ding H; Chen Q; Pan HF
Mol Biol Rep; 2010 Oct; 37(7):3227-32. PubMed ID: 19882361
[TBL] [Abstract][Full Text] [Related]
46. The association between methionine synthase A2756G polymorphism and hematological cancer: A meta-analysis.
Wu B; Liu K; Yang JP; Hu Y; Zhang J; He JX
Medicine (Baltimore); 2017 Dec; 96(48):e7469. PubMed ID: 29310321
[TBL] [Abstract][Full Text] [Related]
47. Association of microRNA-499 rs3746444 polymorphism with cancer risk: evidence from 7188 cases and 8548 controls.
Wang F; Sun G; Zou Y; Li Y; Hao L; Pan F
PLoS One; 2012; 7(9):e45042. PubMed ID: 22970328
[TBL] [Abstract][Full Text] [Related]
48. Correlation between XRCC1 Arg399Gln genetic polymorphisms and susceptibility to bladder cancer: a meta-analysis.
Liu N; Fei X; Shen Y; Shi W; Ma J
Onco Targets Ther; 2016; 9():579-86. PubMed ID: 26869802
[TBL] [Abstract][Full Text] [Related]
49. Association between the STK15 polymorphisms and risk of cancer: a meta-analysis.
Qin J; He XF; Wei W; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Si HQ
Mol Genet Genomics; 2015 Feb; 290(1):97-114. PubMed ID: 25154511
[TBL] [Abstract][Full Text] [Related]
50. GSTM3 A/B polymorphism and risk for head and neck cancer: a meta-analysis.
Xu Y; Wang J; Dong W
PLoS One; 2014; 9(1):e83851. PubMed ID: 24416175
[TBL] [Abstract][Full Text] [Related]
51. The Hsa-miR-27a rs895819 (A>G) polymorphism and cancer susceptibility.
Wang Z; Lai J; Wang Y; Nie W; Guan X
Gene; 2013 May; 521(1):87-90. PubMed ID: 23524006
[TBL] [Abstract][Full Text] [Related]
52. Lack of association between miR-149 C>T polymorphism and cancer susceptibility: a meta-analysis based on 4,677 cases and 4,830 controls.
Zhang J; Liu YF; Gan Y
Mol Biol Rep; 2012 Sep; 39(9):8749-53. PubMed ID: 22714913
[TBL] [Abstract][Full Text] [Related]
53. Apolipoprotein A1 polymorphisms and risk of coronary artery disease: a meta-analysis.
Xu LB; Zhou YF; Yao JL; Sun SJ; Rui Q; Yang XJ; Li XB
Arch Med Sci; 2017 Jun; 13(4):813-819. PubMed ID: 28721149
[TBL] [Abstract][Full Text] [Related]
54. Association of SMAD7 rs12953717 polymorphism with cancer: a meta-analysis.
Zhang H; Ma H; Xu Y; Li L
PLoS One; 2013; 8(3):e58170. PubMed ID: 23472153
[TBL] [Abstract][Full Text] [Related]
55. HuGE systematic review and meta-analysis demonstrate association of CASP-3 and CASP-7 genetic polymorphisms with cancer risk.
Yan S; Li YZ; Zhu XW; Liu CL; Wang P; Liu YL
Genet Mol Res; 2013 May; 12(2):1561-73. PubMed ID: 23765963
[TBL] [Abstract][Full Text] [Related]
56. Effect of CDKN2A/B rs4977756 polymorphism on glioma risk: a meta-analysis of 16 studies including 24077 participants.
Qi X; Wan Y; Zhan Q; Yang S; Wang Y; Cai X
Mamm Genome; 2016 Feb; 27(1-2):1-7. PubMed ID: 26577493
[TBL] [Abstract][Full Text] [Related]
57. CYP3A5*3 polymorphism and cancer risk: a meta-analysis and meta-regression.
Wang BS; Liu Z; Xu WX; Sun SL
Tumour Biol; 2013 Aug; 34(4):2357-66. PubMed ID: 23584898
[TBL] [Abstract][Full Text] [Related]
58. p73 G4C14-A4T14 polymorphism and cancer risk: a meta-analysis based on 27 case-control studies.
Liu F; Liu L; Li B; Wei YG; Yan LN; Wen TF; Xu MQ; Wang WT; Yang JY
Mutagenesis; 2011 Jul; 26(4):573-81. PubMed ID: 21502193
[TBL] [Abstract][Full Text] [Related]
59. Association of LEPR K109R polymorphisms with cancer risk: a systematic review and pooled analysis.
Shi H; Shu H; Huang C; Gong J; Yang Y; Liu R; Yang Y; Liu P
J BUON; 2014; 19(3):847-54. PubMed ID: 25261678
[TBL] [Abstract][Full Text] [Related]
60. TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis.
Wang JJ; Zheng Y; Sun L; Wang L; Yu PB; Dong JH; Zhang L; Xu J; Shi W; Ren YC
Mol Biol Rep; 2011 Nov; 38(8):4847-53. PubMed ID: 21140221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
